Literature DB >> 9006499

A new immunocompetent murine model for oral cancer.

B W O'Malley1, K A Cope, C S Johnson, M R Schwartz.   

Abstract

OBJECTIVE: To develop and characterize a new immunocompetent murine model that attempts to parallel the clinical and biological nature of head and neck cancer.
DESIGN: The growth rate and histologic characteristics of the SCC VII/SF cell line were initially determined in tissue culture experiments. Animal experiments were subsequently performed on C3H/HeJ mice. Using direct injection, 5 x 10(5) SCC VII/SF cells were delivered to the floor of the mouth of each animal. Animals were killed after 1, 2, and 3 weeks, and tumor growth, invasion, and regional and distant metastases were evaluated.
RESULTS: Squamous cell carcinomas that could be palpated and measured externally were identified in the floor of the mouth of C3H/HeJ mice after 5 to 7 days. Local invasion into the mylohyoid musculature and mandible was present. Cervical lymph node and pulmonary metastases were identified between 2 and 3 weeks.
CONCLUSIONS: This study introduces a new oral cancer animal model that shows initial locoregional tumor invasion, direct extension into the neck, early cervical metastases, and pulmonary metastases. These clinical and histopathologic attributes reflect the biological behavior and tumor progression seen in human oral cancer and therefore provide a model for clinically applicable research for primary and metastatic head and neck cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9006499     DOI: 10.1001/archotol.1997.01900010022003

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  19 in total

1.  Tumor vascular microenvironment determines responsiveness to photodynamic therapy.

Authors:  Amanda L Maas; Shirron L Carter; E Paul Wileyto; Joann Miller; Min Yuan; Guoqiang Yu; Amy C Durham; Theresa M Busch
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

2.  Temporal characterization of lymphatic metastasis in an orthotopic mouse model of oral cancer.

Authors:  Peter Szaniszlo; Susan M Fennewald; Suimin Qiu; Carla Kantara; Tuya Shilagard; Gracie Vargas; Vicente A Resto
Journal:  Head Neck       Date:  2014-01-27       Impact factor: 3.147

3.  Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.

Authors:  Anna-Maria A De Costa; Corinne A Schuyler; David D Walker; M Rita I Young
Journal:  Cancer Immunol Immunother       Date:  2011-11-25       Impact factor: 6.968

4.  A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal model.

Authors:  David Hu; Ontario D Lau; Linda Wang; Guanyu Wang; Dorthe Schaue; Li Zhu; Min Huang; Yuan Lin; Miranda Dennis; Elliot Abemayor; David A Elashoff; Steven M Dubinett; William H McBride; Sherven Sharma; Ben Wu; Maie A St John
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-04

Review 5.  Reviewing and reconsidering invasion assays in head and neck cancer.

Authors:  Ronald C Inglehart; Christina S Scanlon; Nisha J D'Silva
Journal:  Oral Oncol       Date:  2014-10-14       Impact factor: 5.337

6.  Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice.

Authors:  Yixiang Wang; Ling Dong; Qingwei Bi; Xiao Li; Dengcheng Wu; Xiyuan Ge; Xiaoxia Zhang; Jia Fu; Chengfei Zhang; Cunyu Wang; Shenglin Li
Journal:  Target Oncol       Date:  2010-11-18       Impact factor: 4.493

7.  Animal models of cancer in the head and neck region.

Authors:  Seungwon Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-06-27       Impact factor: 3.372

8.  Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.

Authors:  Nadège Kindt; Julie Preillon; Herbert Kaltner; Hans-Joachim Gabius; Dominique Chevalier; Alexandra Rodriguez; Bryon D Johnson; Véronique Megalizzi; Christine Decaestecker; Guy Laurent; Sven Saussez
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-25       Impact factor: 4.553

9.  Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib.

Authors:  Jason A Poff; Clint T Allen; Bryan Traughber; Aric Colunga; Jianwu Xie; Zhong Chen; Bradford J Wood; Carter Van Waes; King C P Li; Victor Frenkel
Journal:  Radiology       Date:  2008-06-23       Impact factor: 11.105

10.  A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine model.

Authors:  Yuan Lin; Jie Luo; Weichao Eric Zhu; Minu Srivastava; Dorthe Schaue; David A Elashoff; Steven M Dubinett; Sherven Sharma; Benjamin Wu; Maie A St John
Journal:  Otolaryngol Head Neck Surg       Date:  2014-05-13       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.